Author:
De Marchis Gian Marco,Kriemler Lilian,Seiffge David
Publisher
Springer Berlin Heidelberg
Reference24 articles.
1. Amarenco, P., Lavallée, P.C., Labreuche, J., et al.: One-year risk of stroke after transient ischemic attack or minor stroke. N. Engl. J. Med. 374(16), 1533–1542 (2016)
2. Baigent, C., Blackwell, L., Collins, R., et al.: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678), 1849–1860 (2009)
3. Bath, P.M., Woodhouse, L.J., Appleton, J.P., et al.: Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. The Lancet. 391(10123), 850–859 (2018)
4. Benjamin, E.J., Muntner, P., Alonso, A., et al.: Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139(10), e56–e528 (2019 März)
5. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348, 1329–1339 (1996)